NextCure (NXTC) Gains (Losses) on Sale of Assets & Investments (2019 - 2026)
NextCure (NXTC) recorded Gains (Losses) on Sale of Assets & Investments of $3,000 in Q3 2026, down 87.5% from $24,000 a year earlier.
NextCure (NXTC) Gains (Losses) on Sale of Assets & Investments (2019 - 2026) Analysis & Trends
On a TTM basis, NextCure's Gains (Losses) on Sale of Assets & Investments came in at -$17,000 as of Sep 30, 2026; for FY2025, it was $17,000, down 92.5% from FY2024.
- Annual Gains (Losses) on Sale of Assets & Investments has a five-year compound annual growth rate of -53.5% (FY2020 to FY2025).
- Across earlier years, Gains (Losses) on Sale of Assets & Investments came in at $226,000 in FY2024 (-82.2%), $1.27 million in FY2023, -$831,000 in FY2022 and -$1.44 million in FY2021.
- Quarterly Gains (Losses) on Sale of Assets & Investments has ranged from -$1.54 million in Q1 2022 to $691,000 in Q1 2023 over the past five years.
- Per Business Quant, the preceding three quarters came in at -$1,000 (Q2 2026), -$23,000 (Q1 2026) and $4,000 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gains on Sales (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | - |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | - |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | - |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | - |
| 10 | NextCure | 29.30 Mn | -71.08 Mn | - | 3,000.00 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3,000.00 |
| Jun 30, 2026 | -1,000.00 |
| Mar 31, 2026 | -23,000.00 |
| Dec 31, 2025 | 4,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Jun 30, 2025 | -7,000.00 |
| Mar 31, 2025 | -4,000.00 |
| Dec 31, 2024 | -72,000.00 |
| Sep 30, 2024 | 162,000.00 |
| Jun 30, 2024 | 96,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Dec 31, 2023 | 381,000.00 |
| Sep 30, 2023 | 322,000.00 |
| Jun 30, 2023 | -122,000.00 |
| Mar 31, 2023 | 691,000.00 |
| Dec 31, 2022 | -831,000.00 |
| Sep 30, 2022 | -56,000.00 |
| Jun 30, 2022 | -141,000.00 |
| Mar 31, 2022 | -1.54 Mn |
| Dec 31, 2021 | -534,000.00 |
NextCure Gains (Losses) on Sale of Assets & Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=NXTC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "NXTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=NXTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();